These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11697682)

  • 1. Dementia in Parkinson's disease.
    Korczyn AD
    J Neurol; 2001 Sep; 248 Suppl 3():III1-4. PubMed ID: 11697682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia with Lewy bodies.
    Korczyn AD; Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):3-8. PubMed ID: 17034818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction and dementia in Parkinson's disease.
    Bosboom JL; Stoffers D; Wolters ECh
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1303-15. PubMed ID: 15480840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Parkinson's disease dementia : practical considerations.
    Rongve A; Aarsland D
    Drugs Aging; 2006; 23(10):807-22. PubMed ID: 17067184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory deficits in advanced Parkinson's disease.
    Fischer P; Gatterer G; Simanyi M; Jellinger K; Marterer A; Danielczyk K; Danielczyk W
    J Neural Transm Park Dis Dement Sect; 1990; 2(1):59-70. PubMed ID: 2357271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases].
    Chukhlovina ML
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):79-82. PubMed ID: 25202788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinson syndrome and cognitive disorders].
    Szirmai I; Kovács T
    Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia associated with Parkinson's disease.
    Emre M
    Lancet Neurol; 2003 Apr; 2(4):229-37. PubMed ID: 12849211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular contribution to dementia in Parkinson's disease.
    Korczyn AD
    Neurodegener Dis; 2010; 7(1-3):127-30. PubMed ID: 20173342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivastigmine in Parkinson's disease dementia.
    Lalli S; Albanese A
    Expert Rev Neurother; 2008 Aug; 8(8):1181-8. PubMed ID: 18671661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewy body cortical involvement may not always predict dementia in Parkinson's disease.
    Colosimo C; Hughes AJ; Kilford L; Lees AJ
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):852-6. PubMed ID: 12810766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to cholinergic deficiency in Lewy body diseases.
    Barrett MJ; Cloud LJ; Shah H; Holloway KL
    Expert Rev Neurother; 2020 Jan; 20(1):41-53. PubMed ID: 31577469
    [No Abstract]   [Full Text] [Related]  

  • 17. Rivastigmine for dementia associated with Parkinson's disease.
    Emre M; Aarsland D; Albanese A; Byrne EJ; Deuschl G; De Deyn PP; Durif F; Kulisevsky J; van Laar T; Lees A; Poewe W; Robillard A; Rosa MM; Wolters E; Quarg P; Tekin S; Lane R
    N Engl J Med; 2004 Dec; 351(24):2509-18. PubMed ID: 15590953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibitors for Parkinson's disease dementia.
    Maidment I; Fox C; Boustani M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.